Danaher

September 8, 2016
Danaher Strengthens Molecular Diagnostics Portfolio with $4B Acquisition of Cepheid

Danaher Strengthens Molecular Diagnostics Portfolio with $4B Acquisition of Cepheid

Danaher has announced the acquisition of medical diagnostics company Cepheid, bolstering their presence in the Molecular Diagnostics market. Danaher Corporation will pay $53 per share in […]
Contact Us